The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(Chroman-8-yl)-2-(cyclopropanesulfonamido)benzamide ID: ALA5186474
Chembl Id: CHEMBL5186474
PubChem CID: 168278611
Max Phase: Preclinical
Molecular Formula: C19H20N2O4S
Molecular Weight: 372.45
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cccc2c1OCCC2)c1ccccc1NS(=O)(=O)C1CC1
Standard InChI: InChI=1S/C19H20N2O4S/c22-19(20-17-9-3-5-13-6-4-12-25-18(13)17)15-7-1-2-8-16(15)21-26(23,24)14-10-11-14/h1-3,5,7-9,14,21H,4,6,10-12H2,(H,20,22)
Standard InChI Key: TZIVSSAHFHYQJW-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.45Molecular Weight (Monoisotopic): 372.1144AlogP: 3.17#Rotatable Bonds: 5Polar Surface Area: 84.50Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.60CX Basic pKa: ┄CX LogP: 2.53CX LogD: 2.35Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.84Np Likeness Score: -1.17
References 1. Sharma S, Peng Q, Vadukoot AK, Aretz CD, Jensen AA, Wallick AI, Dong X, Hopkins CR.. (2022) Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1., 13 (5.0): [PMID:35586421 ] [10.1021/acsmedchemlett.2c00100 ]